Funding Update: Current Situation and Future Prospects

Slides:

Advertisements

Similar presentations

Global Measles and Rubella Strategic Plan

Advertisements

Measles elimination in the African Region- Regional updates

Measles Outbreaks in Southern Africa in 2010 Presentation to the MI 10 th annual meeting Sept 2011 B Masresha WHO AFRO.

Measles and Rubella Elimination in the WHO European Region: Update on Progress & Challenges Global Measles and Rubella Management Meeting March 2011.

The Cape Verde experience with rubella outbreak & lessons from introducing rubella vaccines MoH Cape Verde ARCI meeting Dar es Salaam, Tanzania Dec 2012.

A global partnership to stop measles & rubella The Measles & Rubella Initiative: Preparing for the Next Decade Lisa Cairns, MD, MPH Sept 18, 2012 Washington,

Measles control and elimination in the Eastern Mediterranean Region

Proceedings of the SAGE Working Group on Rubella Vaccines Susan E. Reef, MD Global Measles and Rubella Management Meeting March 15, 2011.

The partners,initiatives, alliances, groups and meetings within world of the Expanded Programme on Immunization Quick overview 25-September-2012 GID presentation.

Global Measles and Rubella Management Meeting Progress and Challenges in Bangladesh March, 2011 Geneva, WHO HQ Dr Serguei Diorditsa.

Ann Levin, Colleen Burgess, Lou Garrison, Chris Bauch, and Joseph Babigumira Measles Initiative Meeting Washington, D.C. September 13,

Reaching the 2010 Measles Mortality Reduction Goal-can SEARO get there? Meeting of the Partners for Measles Advocacy Washington DC, September 2008.

Measles Initiative Financing February 28, 2007 Washington, D.C. Andrea Gay UN Foundation for Measles Partners.

Progress towards Sustainable Measles Mortality Reduction South-East Asia Region Jayantha Liyanage Medical Officer- EPI Immunization and Vaccine Development.

1 1 Measles elimination and rubella control in the SEA Region- a brief Update 12 th Annual Meeting of the Measles Rubella Initiative (MRI) September,

IMMUNIZATION IN UGANDA Dan Wamanya IMMUNIZATION IN UGANDA Dan Wamanya USAID/Uganda.

Edward J. Hoekstra, MD, MSc Edward J. Hoekstra, MD, MSc Senior Health Advisor Senior Health Advisor UNICEF HQ, New York UNICEF HQ, New York Peter Strebel,

Palestine Bahrain Global Measles and Rubella Management Meeting Boubker Naouri March, 2011 Geneva, WHO HQ.

MEASLES MORTALITY REDUCTION IN INDIA Status and Future Plans.

Measles Initiative Management and Financing September 13, 2011.

1 1 Bose: SEAR Highlights and Priorities Global Measles & Rubella Management Meeting Geneva, March 2011 Accelerated Measles Control: Highlights and.

1 Progress Towards Global and Regional Immunization Goals Workshop on Prevention and Control of Vaccine Preventable Disease in Displaced Person Temporary.

Funding Update: 2013 – 2015 September 10,

Funding Update GMMM March 21, 2012 Andrea Gay, UNF Athalia Christie, ARC Rebecca Martin, CDC 1.

Measles pre-elimination in the African Region. Presentation to the MI 10 th annual meeting Sept 2011 B Masresha WHO AFRO.

Global Overview of Measles & Rubella 11 th Annual Meeting The Measles Initiative Washington, DC th September, 2012.

Regional measles elimination program updates B Masresha WHO AFRO AFR MR TAG Meeting Nairobi, June 2015.

AFR MR TAG Global Measles and Rubella Update 5 th African Regional Measles/Rubella TAG Meeting 2 nd -3 rd June 2015.

1 |1 | Measles pre-elimination and resurgence in the African region Balcha Masresha IVD AFRO Global Measles Management Meeting Geneva March 2011.

WHO EURO In Country Coordination and Strengthening National Interagency Coordinating Committees.

Sudan EPI Benefits From Polio Eradication Program M&RI Annual Partners Meetings Washington D.C September 2015 Sudan EPI Benefits From Polio Eradication.

MR introduction and rubella epidemiology in AFRO Regional MR TAG Nairobi, Kenya June 2-3, 2015.

Update on Progress toward Measles Situation in EMR September 2008 Dr B. Naouri VPI/DCD/EMRO.

World Health Organization By: Carl Bates, Austin Magnuson, Rachel Yerkey, Makayla Kitzmiller.

Measles Mortality Reduction: the risk of resurgence Global Immunization Meeting Geneva, Switzerland 1-3 February 2010 Balcha Masresha, WHO/AFRO.

2015 Measles & Rubella Initiative Annual Partners Meeting, Human & Financial Costs of Measles and Rubella, 15 September 2015, Washington, DC Achieving.

A global partnership to stop measles & rubella 1 Measles & Rubella Initiative --Who We Are-- Stephen Cochi, MD, MPH Global Immunization Division Centers.

12 th Annual Meeting of The Measles & Rubella Initiative American Red Cross, Washington, DC September, 2013.

12 th Annual Meeting The Measles & Rubella Initiative Western Pacific Regional Update: The Final Push September 2013 American Red Cross National.

Sustaining the gains and reaching milestones on the way towards elimination of measles and rubella 15 September 2015 Dr Peter Strebel, WHO, IVB/EPI.

Measles and Rubella Initiative Financial Resource Requirements for Measles and Rubella Annual Partners Meeting, September

World Health Organization Western Pacific Regional Office Expanded Programme on Immunization Measles Elimination in the Western Pacific Region 2007 Partners.

Accelerating Progress towards Measles and Rubella Elimination WHO Western Pacific Region UNICEF East Asia and Pacific Region 1 21 June 2016 Geneva, Switzerland.

Accelerating Progress towards Measles and Rubella Elimination Eastern Mediterranean Region 1 21 June 2016 Geneva, Switzerland.

GAVI’S NEW MEASLES AND RUBELLA STRATEGY Dr. Khin Devi Aung Gavi Secretariat 21 June 2016, Geneva 1 #vaccineswork.

Measles & Rubella Initiative Advocacy & Communication

Global Measles and Rubella: Highlights, Priorities and Critical Issues

Accelerating Progress towards Measles and Rubella Elimination in AFR

12th Annual Meeting of the Measles and Rubella Initiative

Global Overview of Measles

Midterm Review of the Global Measles and Rubella Strategic Plan 2012 – 2020 Summary of the Findings and Implementation Status Dr Kaushik Banerjee M&RI.

World Health Organization

World Health Organization

Accelerating Progress towards Measles and Rubella Elimination

Measles & Rubella Initiative Partners meeting September 7-8, 2017

World Health Organization

Recap of the Midterm Review Recommendations

Session 1: New Opportunities and New Direction

آشنايي با نظام سلامت.

مراقبت بيماريهاي بثوري تب دار باهدف حذف سرخك و سرخجه

23 November, 2018 Update on measles & rubella surveillance in the WHO African Region – progress and challenges Dr Richard Luce WHO/IST-Central 5th African.

Stakeholder Consultation

African Region- priorities to reach the 2020 measles elimination goal.

Experience with the measles outbreak response fund

July 21, 2016 Potential Domestic Source Financing for Scaled Up Antiretroviral Therapy in 97 Countries, 2016–2020 Arin Dutta, Catherine Barker, and Ashley.

Mectizan Donation for IDA countries

State of Measles Initiative Financing Partners for Measles Advocacy Meeting Washington, D.C. September 22, 2008 Andrea Gay.

Partners for Measles Advocacy—7th Annual Meeting

Measles and Rubella Elimination Goals by WHO Region, 2012

Simple average price of the most sold brand in international dollars (PPP), excise tax per pack and total tax share by WHO region, Column labels.

Presentation transcript:

Funding Update: Current Situation and Future Prospects September 18, 2012 Andrea Gay, UNF

MR Initiative Annual Expenditure, 2001-2012 Total expenditure 2001-2012 = $935 million * Excluding country contributions

Measles & Rubella Initiative Annual Donations 2001-2012 and Financial Resource Requirements, Projections, Funding Gap 2012-2015* 94 59 11 36 38 44 Excl. country contrib. * Excludes all country contributions and direct social mobilization funding from partners

Measles & Rubella Initiative Financial Resource Requirements, Projections, Funding Gap 2013-2015 47 Total Funding Gap 2013-2015: US $96 million 32 18 31 Incl. country contrib. Anticipated Country Contributions Anticipated GAVI Contribution (Rubella) Donor Funds Projected/Pledged/Received Funding Gap (includes PSC)

Resource Requirements by Major Category of Activity, 2013-2015 Total Cost 2013-2015: US $739 million

MR Initiative Donors, 2001-2012 * Includes ARC/UNF and other partners

Where is the Measles & Rubella Initiative Headed? 2012 measles goals: AFRO (pre-elimination) and WPRO (elimination) 2013 potential SEARO elimination goal set, begin MR introduction campaigns with GAVI support 2015 GIVS (95% mortality reduction) and MDG 4 goals; measles goal in EMRO and EURO (elimination); rubella goal in EURO (elimination) 2020 goal in AFRO (elimination) Expand rubella introduction where appropriate; set goals Critical Elements for Success Political leadership Timely funding (donor and national governments) Adequate time for planning and social mobilization Well performing surveillance

Measles and rubella elimination goals by WHO Region, March 2012 World Health Organization 18 January, 2019 Measles and rubella elimination goals by WHO Region, March 2012 2015 2015 2000 2010 2015 2012 SEARO RC in Sept 2009 endorsed a resolution to mobilize support towards eliminate measles, 2010 RC meeting adopted the global 2015 measles targets (95% mortality reduction). Note: EURO changed target to 2015, EMRO is in process of changing target to 2015 2020 Pre-elim. (98%) 2012 SEAR: 95% Measles Mortality Reduction by 2015 Elimination 2020? Americas, Europe, E. Mediterranean, W. Pacific, Africa have measles elimination goals Americas and Europe have rubella elimination goals 8

Considerations for Reorganizing Aspects of MR Initiative Operations Measles eradication investment case (EIC): research, costing options Strategic funding for regional elimination goals Strategic support for non-GAVI eligible countries Increased surveillance costs (including lab, coverage surveys) Increased communications costs Increased training costs for SIAs Type of MR Initiative involvement (ex: T.A.) in GAVI funded MR intro SIAs or GAVI funded measles SIAs in 6 large countries Outbreak response fund Routine immunization Scale up of MCV1 Increase MCV2 introduction Rubella & CRS (MR) Follow-up campaigns